Search Results - "DI COSTANZO, Gianna"

Survival prediction and frequency of anticancer treatment in cancer patients hospitalized due to acute conditions. Role of clinical parameters and PaP score by Numico, Gianmauro, Occelli, Marcella, Russi, Elvio G., Silvestris, Nicola, Pasero, Raffaella, Fea, Elena, Granetto, Cristina, Di Costanzo, Gianna, Colantonio, Ida, Gasco, Milena, Garrone, Ornella, Polla, Valentina, Merlano, Marco C.

“…Purpose Survival prediction is useful in selecting patients for palliative care or active anticancer therapy. The palliative and prognostic (PaP) score was…”
Get full text

A phase II study of epirubicin, vinorelbine and cisplatin in advanced breast cancer by Garrone, Ornella, Principe, Ernesto, Occelli, Marcella, Mercuri, Michelangelo, Numico, Gianmauro, Granetto, Cristina, Costanzo, Gianna Di, Rattazzi, Pier Dino, Merlano, Marco

“…Our objective was to evaluate the activity and safety of the combination of cisplatin, epirubicin and vinorelbine (CEV) in advanced breast cancer patients…”
Get full text

Treating patients with cancer amidst the COVID-19 pandemic: experience of a regional hospital in the Piedmont region in northern Italy by Garrone, Ornella, Denaro, Nerina, Ruatta, Fiorella, Vanella, Paola, Granetto, Cristina, Vandone, Anna Maria, Occelli, Marcella, Cauchi, Carolina, Ricci, Vincenzo, Fea, Elena, Di Costanzo, Gianna, Colantonio, Ida, Crosetto, Nicola, Merlano, Marco C.

“…Background: The coronavirus disease 2019 (COVID-19) pandemic is posing an unprecedented dilemma to oncologists worldwide, forcing them to decide whether to…”
Get full text

Prospective evaluation of major vascular events in patients with nonsmall cell lung carcinoma treated with cisplatin and gemcitabine by Numico, Gianmauro, Garrone, Ornella, Dongiovanni, Vincenzo, Silvestris, Nicola, Colantonio, Ida, Di Costanzo, Gianna, Granetto, Cristina, Occelli, Marcella, Fea, Elena, Heouaine, Abdelamid, Gasco, Milena, Merlano, Marco

“…BACKGROUND Cancer and cisplatin‐based chemotherapy both are well recognized risk factors for coagulation disorders and thrombosis. However, vascular events…”
Get full text

Single-agent pegylated liposomal doxorubicin (Caelix®) in chemotherapy pretreated non-small cell lung cancer patients: a pilot trial by Numico, Gianmauro, Castiglione, Federico, Granetto, Cristina, Garrone, Ornella, Mariani, Gabriella, Costanzo, Gianna Di, Ciura, Pietro La, Gasco, Milena, Ostellino, Oliviero, Porcile, Gianfranco, Merlano, Marco

“…Polyethylene glycol-coated (pegylated) liposomal doxorubicin (PLD) is a new formulation of doxorubicin with peculiar pharmacokinetic and pharmacodinamic…”
Get full text

Carboplatin and Weekly Paclitaxel in Non-small Cell Lung Cancer Patients Unfit for or Pretreated with Chemotherapy by NUMICO, Gianmauro, COLANTONIO, Ida, RUSSI, Elvio, MERLANO, Marco, GASCO, Milena, BERTELLI, Gianfilippo, GARRONE, Ornella, OCCELLI, Marcella, FEA, Elena, DI COSTANZO, Gianna, GRANETTO, Cristina, HEOUAINE, Abdelamid

“…Background: Carboplatin-Paclitaxel is one of the most active regimens in non-small cell lung cancer (NSCLC). We assessed the administration of weekly…”
Get full text

T memory cells in the tumor invasive margins affect survival in colon cancer (CC) but not in breast cancer (BC) by Merlano, Marco Carlo, Ricci, Vincenzo, Garrone, Ornella, Ferrero, Martina, Vivenza, Daniela, Granetto, Cristina, Miraglio, Emanuela, Cauchi, Carolina, Denaro, Nerina, Occelli, Marcella, Fea, Elena, Vandone, Anna Maria, Vanella, Paola, Di Costanzo, Gianna, Colantonio, Ida, Varamo, Chiara, Lattanzio, Laura, Lo Nigro, Cristiana, Comino, Alberto

“…Abstract only…”
Get full text

Gemcitabine and cisplatin in a concomitant alternating chemoradiotherapy program for locally advanced head-and-neck cancer: a pharmacology-guided schedule by Numico, Gianmauro, Russi, Elvio G, Vitiello, Raffele, Sorrentino, Raffaele, Colantonio, Ida, Cipolat, Marco, Taglianti, Riccardo Vigna, Pelissero, Antonio, Fea, Elena, Granetto, Cristina, Di Costanzo, Gianna, Gasco, Milena, Garrone, Ornella, Occelli, Marcella, Merlano, Marco

“…Administration of gemcitabine together with cisplatin at cytotoxic doses in a chemoradiotherapy regimen is hampered by a high degree of local toxicity. Using…”
Get more information

Variation in gynecological oncology follow-up practice: Attributable to cancer centers or to patient characteristics? A Piedmont Regional Oncology Network Study by Fuso, Luca, Evangelista, Andrea, Pagano, Eva, Piovano, Elisa, Perotto, Stefania, Mazzola, Simona, Bertoldo, Emiliana, La Porta, Maria Rosa, Rosmino, Claudia, Furbatto, Graziella, Abate, Sergio, Di Costanzo, Gianna, Trossarelli, Gianfranco, Baù, Maria Grazia, Carnino, Flavio, Gambaro, Giuseppina, Piantanida, Paola, Alabiso, Oscar, Galletto, Luciano, Zavallone, Laura, Rossi, Annalisa, Barbero, Maggiorino, Tessa, Maria, Katsaros, Dionyssios, Danese, Saverio, Brignolo, Paola, Gorzegno, Gabriella, Grillo, Raffaella, Apolone, Giovanni, Ciccone, Giovannino, Zola, Paolo

“…Aims and background Although guidelines recommend minimalist follow-up, there is wide variability in gynecological oncology practice. The aims of this study…”
Get full text

Paclitaxel, cisplatin, 5-fluorouracil and radiotherapy in the management of advanced squamous cell carcinoma of the head and neck. A phase II trial by Merlano, Marco, Russi, Elvio G., Numico, Gianmauro, Colantonio, Ida, Garrone, Ornella, Pelissero, Antonio, Granetto, Cristina, Gasco, Milena, Di Costanzo, Gianna, Heouaine, Abdelhamid, Vigna Taglianti, Riccardo, Cipolat, Marco

“…Aim of the present study was to test, activity and toxicity of a rapidly alternating chemoradiation (paclitaxel based) in 31 patients with unresectable,…”
Get full text

Topotecan and ifosfamide as salvage treatment in advanced ovarian cancer by Chiara, Silvana, Tognoni, Alessandra, Pastrone, Ilaria, Tomasello, Laura, Brema, Fulvio, Di Costanzo, Gianna, Folco, Ugo, Pronzato, Paolo

“…Objective. The purpose of the study was to evaluate activity and toxicity of the combination of topotecan and ifosfamide as salvage treatment in patients with…”
Get full text

Variation in gynecological oncology follow-up practice: attributable to cancer centers or to patient characteristics? A Piedmont Regional Oncology Network Study by Fuso, Luca, Evangelista, Andrea, Pagano, Eva, Piovano, Elisa, Perotto, Stefania, Mazzola, Simona, Bertoldo, Emiliana, La Porta, Maria Rosa, Rosmino, Claudia, Furbatto, Graziella, Abate, Sergio, Di Costanzo, Gianna, Trossarelli, Gianfranco, Baù, Maria Grazia, Carnino, Flavio, Gambaro, Giuseppina, Piantanida, Paola, Alabiso, Oscar, Galletto, Luciano, Zavallone, Laura, Rossi, Annalisa, Barbero, Maggiorino, Tessa, Maria, Katsaros, Dionyssios, Danese, Saverio, Brignolo, Paola, Gorzegno, Gabriella, Grillo, Raffaella, Apolone, Giovanni, Ciccone, Giovannino

“…AIMS AND BACKGROUNDAlthough guidelines recommend minimalist follow-up, there is wide variability in gynecological oncology practice. The aims of this study…”
Get full text